We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Hologic

Designs and provides products for clinical laboratory and blood screening, including testing items for detection of h... read more Featured Products: More products

Download Mobile App





Hologic Awarded USD 7.6 Million by HHS and DOD to Ramp Up Capacity for COVID-19 Tests

By LabMedica International staff writers
Posted on 06 Aug 2020
Print article
Illustration
Illustration
The US Department of Health & Human Services (HHS Washington, D.C., USA) and Department of Defense (DOD Arlington, VA, USA) have awarded an undefinitized contract action with a ceiling of USD 7.6 million to Hologic, Inc. (Marlborough, MA, USA) to expand production of custom sample collection and processing consumables for COVID-19 testing.

The unprecedented demand for molecular diagnostic testing driven by the COVID-19 pandemic had exceeded Hologic’s production capacity for sample collection and processing consumables. The company is well-positioned to support the demand for COVID-19 testing in the US due to the installed base of more than 1,100 fully automated, high throughput Panther and Panther Fusion systems. These Panther systems are each capable of performing more than 1,000 tests in a 24-hour period. The tube, cap, and multi-tube unit consumables are critical for performing molecular diagnostic tests on the Panther and Panther Fusion systems.

Hologic has received ongoing support to develop the COVID-19 test for these systems from the Biomedical Advanced Research and Development Authority, part of the HHS Office of the Assistant Secretary for Preparedness and Response. The latest investment will increase Hologic's production from 4.8 million COVID-19 tests per month to 6.8 million tests per month. The company is expected to deliver the increased volume of consumables to market by January 2021.

“The Trump Administration’s coordination across the Federal government is important toward the successful execution of our national testing strategy to fight COVID-19,” said HHS Assistant Secretary for Health ADM Brett Giroir, M.D. “Hologic’s platform is in high demand, and with this investment, we will be able to improve the supply to laboratories across the country.”


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
SARS-CoV-2 Test
One Step SARS-CoV-2 Nucleic Acid Detection Kit (P761H)

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The cobas Malaria test is the first FDA-approved molecular test to screen U.S. blood donors for malaria (Photo courtesy of Roche)

First FDA-Approved Molecular Test to Screen Blood Donors for Malaria Could Improve Patient Safety

Malaria, a serious illness that often leads to death, is spread by a specific mosquito species that infect humans with a parasite. Other transmission modes include blood transfusions, organ transplants,... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The medical office procedure detects the key biomarker in Parkinson’s and related neurodegenerative diseases (Photo courtesy of BIDMC)

Simple Skin Biopsy Test Detects Parkinson’s and Related Neurodegenerative Diseases

Parkinson's disease and a group of related neurodegenerative disorders known as synucleinopathies impact millions globally. These conditions, including Parkinson’s disease (PD), dementia with Lewy bodies... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.